Učitavanje...
A modular phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy
PURPOSE: Lenalidomide, a highly-potent immunomodulatory derivative of thalidomide, potentiates the action of paclitaxel in-vitro against prostate cancer cell lines in co-culture with mononuclear cells. A modular Phase I study of lenalidomide and paclitaxel in men with metastatic castration-resistant...
Spremljeno u:
| Izdano u: | Cancer Chemother Pharmacol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436674/ https://ncbi.nlm.nih.gov/pubmed/20052472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1237-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|